EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 3.0

Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases

Zijie Yu iD, Zhihong Sun, Lu Yuan, Cuicui Wang, Wei Li, Jie Liu, Qi Zhao, Yong Sun iD, Chengming Sun

International Journal of Nanomedicine · 2025-10 · Volume 20 · 12593-12625

DOI: 10.2147/ijn.s545696 ↗

At a glance

Übersichtsarbeit in International Journal of Nanomedicine, 2025-10. Written by Zijie Yu and 8 co-authors. Institution: Department of Pharmaceutics, School of Pharmacy, Qingdao Medical College, Qingdao University, Qingdao, Shandong, People's Republic of China. Major MEDLINE topics: Blood-Brain Barrier, Brain Diseases, Nanoparticles, Drug Carriers. Cited 7 times so far (Crossref); 189 references. The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Brain diseases have become an important health problem worldwide, especially in the aging population, and their incidence and prevalence continue to increase. Despite remarkable progress in medical technology, the treatment of brain diseases still faces many challenges, especially limitations caused by the blood-brain barrier (BBB), which significantly hinders the delivery of therapeutic drugs to the brain. In recent years, non-viral nanocarriers developed by nanotechnology have shown great potential for crossing the BBB, and have attracted much attention due to their low immunogenicity, high biocompatibility and good targeting. In this paper, we review the basic structure of the BBB, properties of nonviral vectors, and the mechanisms of crossing BBB. Moreover, this review summarizes the main types of non-viral vectors-liposomes, polymeric nanoparticles, biomimetic materials, and inorganic nanomaterials-while addressing the main translational barriers, including low BBB permeability, poor systemic stability, nonspecific peripheral accumulation, manufacturing challenges, and limited clinical validation, and suggests future research directions.

Subjects

MeSH terms (MEDLINE)

Blood-Brain BarrierBrain DiseasesNanoparticlesDrug CarriersHumansAnimalsPermeabilityLiposomesDrug Delivery Systems

Author keywords

blood-brain barrierbrain diseasesbrain drug deliverynon-viral nanocarriers

Substances

Drug CarriersLiposomes

Authors and institutions

  • Department of Pharmaceutics, School of Pharmacy, Qingdao Medical College, Qingdao University, Qingdao, Shandong, People's Republic of China.
  • The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, People's Republic of China.

ORCID profiles: Zijie Yu, Yong Sun

Cite

APA

Yu, Z., Sun, Z., Yuan, L., Wang, C., Li, W., Liu, J., Zhao, Q., Sun, Y., & Sun, C. (2025). Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases. International Journal of Nanomedicine, Volume 20, 12593-12625. https://doi.org/10.2147/ijn.s545696

Vancouver

Yu Z, Sun Z, Yuan L, Wang C, Li W, Liu J, et al. Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases. International Journal of Nanomedicine. 2025;Volume 20:12593-12625. doi:10.2147/ijn.s545696

BibTeX
@article{Yu2025,
  author = {Yu, Zijie and Sun, Zhihong and Yuan, Lu and Wang, Cuicui and Li, Wei and Liu, Jie and Zhao, Qi and Sun, Yong and Sun, Chengming},
  title = {Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {12593--12625},
  doi = {10.2147/ijn.s545696}
}
Start for free →